
Posted May 02, 2019 05:10:47 A new form of medicine that aims to help fight hyperkalaemia is making waves in the US.
The treatment, which uses nitric oxide to help prevent damage from anemia and other diseases, was developed by a group of doctors in the UK.
But a number of scientists have questioned the effectiveness of this treatment in humans, including Dr. Matthew Green, a professor of pediatrics at the University of Edinburgh who is the co-author of the Lancet medical journal article.
He and his team tested the nitric-oxide treatment in a group that had suffered from hyperkaliaemia, a condition in which the body produces too much nitric acid, and found that the treatment did not improve symptoms in a majority of people.
Nitric oxide is a molecule that is found in the human body and is a natural gas.
This means that it is a form of oxygen and, in addition to protecting the body from free radicals, is a vital chemical for cells.
If you are hyperkalytic, the body will produce more nitric ions.
So it makes sense that this form of therapy would help you to prevent hyperkalanemia.
However, Dr. Green says that it’s important to understand how it works and what it is doing to your body.
“I think it is important to be aware that there is no magic bullet.
You can’t just give people the nitrate solution, but I do believe that you can work with the diet, with exercise, with other lifestyle factors that might be helping to improve your blood pressure, and with the exercise, the lifestyle factors, which can also improve the health of your body,” he said.
Dr. Green and his colleagues found that while they had significantly improved their symptoms, it was not enough to reverse hyperkallemia.
So they started looking at how the treatment might help people who are also at high risk of hyperkalgassemia.
The researchers tested a group with a high risk for hyperkaloemia.
They gave them a blood test to determine the level of nitrate in their blood.
Then they put the patients in a controlled environment, such as a hospital or an emergency department, and asked them to take a nitricoxide-rich diet.
When the researchers did this, they found that a very small proportion of people who had been treated with nitric Oxide had regained hyperkalinemia symptoms.
In other words, it did not seem that this treatment worked.
They then took the same group of people and gave them the same nitric oxygen-rich Diet.
These were people who were also at higher risk of developing hyperkalfasemia.
The results, however, were the opposite: The treatment did help.
Now Dr. Greens team is working on testing this treatment on a larger scale.
It’s hoped that this could be rolled out in the coming months, so that it could be more widely used.
But he also said that it should be possible to take the treatment in the form of a pill.
One thing to remember, Dr Green says, is that these people should not be taking nitric as they are unlikely to get it in the pill form.
There’s also the question of whether this is safe.
Scientists from the University College London recently reported that nitric O2 can be absorbed into the body through the skin and the mucus membranes, so they should be safe for the body to use, but it’s not known whether this would be the case in humans.
What’s next?
Dr Green says the next step is to see if this treatment works in people who have never been treated before, but are likely to be at high-risk of hyperkyalemia.
He also says that the treatments could be extended to include people with multiple conditions.
To find out more about hyperkaleemia, watch this video: